v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities        
Net loss $ (27,256) $ (6,978) $ (9,230) $ (10,281)
Adjustments to reconcile net loss to net cash used in operating activities:        
Non-cash interest expense 2,496 3,138 4,424 4,283
Gain on change in fair value of related party convertible debt (198) 427 311 22
Noncash issuance of inducement shares in connection with the merger 7,584 2    
Noncash issuance of warrants associated with ELOC costs 982    
Loss on disposition of property and equipment, net     2
Stock-based compensation expenses 704 16 21 33
Change in fair value of warrant liabilities (884)    
Loss on change in fair value of digital assets 28    
Changes in assets and liabilities:        
Other receivables 45 45 (45)
Prepaid expenses and other current assets (118) 97 77 (64)
Other non-current assets 1 (346) (25) (1)
Accounts payable and accrued expenses 3,197 690 645 533
Accrued liabilities 2,345 1,081 1,664 1,118
Net cash used in operating activities (11,119) (1,828) (2,066) (4,402)
Purchase of digital assets (1,000)    
Cash flows from investing activities        
Property and equipment, net     (2)
Net cash used in investing activities (1,000) (2)
Cash flows from financing activities        
Proceeds from issuance of senior notes     3,210 3,235
Proceeds from issuance of convertible loan   16 16 1,600
Net cash received from the reverse recapitalization 2    
Repayment of convertible notes (1,052) (150)    
Proceeds from issuance of notes 1,450 2,110    
Proceeds from ELOC 3,537    
Proceeds from issuance of promissory notes 11,000 375
Repayment of senior notes     (150)
Repayment of related party promissory notes     (151)
Payment of deferred offering costs (150) (961) (614)
Proceeds from issuance of common stock upon exercise of stock options     23
Net cash used in financing activities 14,937 1,826 2,115 4,468
Net change in cash 2,818 (2) 49 64
Cash and Restricted Cash, Beginning of the period 191 142 142 78
Cash, end of the period 3,009 140 191 142
Supplemental disclosures of non-cash investing and financing information:        
Assumption of net liabilities of Northview 12,346    
Issuance in shares in connection with convertible note 7,254    
Increase (decrease) in unpaid deferred offering costs (32) $ 269 $ 72
Issuance in shares in connection with ELOC transaction costs 3,537    
Issuance of warrants in connection with ELOC costs 982    
Issuance in shares in connection with non-recourse note to employees 428    
Conversion of preferred stock into common stock 65,149    
Issuance of HCW warrants in lieu of cash payment 330    
Conversion of debt to equity 46,891    
Supplemental disclosure of cash flow information:        
Cash paid for interest 250    
Cash paid for taxes $ 13